Bombesin-functionalized superparamagnetic iron oxide nanoparticles for dual-modality MR/NIRFI in mouse models of breast cancer

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Stewart BW, Wild CP. World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer; 2014.
   Google Scholar
• Zheng XC, Ren W, Zhang S, et al. The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles. Int J Nanomedicine. 2018;13:1495–1504. doi:10.2147/IJN.S15708229559778
   PubMed Web of Science ®Google Scholar
• Kim JS, Kim YH, Kim JH, et al. Development and in vivo imaging of a PET/MRI nanoprobe with enhanced NIR fluorescence by dye encapsulation. Nanomedicine (Lond). 2012;7(2):219–229. doi:10.2217/nnm.11.9422175235
   PubMed Web of Science ®Google Scholar
• Bennett KM, Jo J, Cabral H, Bakalova R, Aoki I. MR imaging techniques for nano-pathophysiology and theranostics. Adv Drug Deliv Rev. 2014;74:75–94. doi:10.1016/j.addr.2014.04.00724787226
   PubMedGoogle Scholar
• Albanese C, Rodriguez OC, VanMeter J, et al. Preclinical magnetic resonance imaging and systems biology in cancer research: current applications and challenges. Am J Pathol. 2013;182(2):312–318. doi:10.1016/j.ajpath.2012.09.02423219428
   PubMed Web of Science ®Google Scholar
• Zhao J, Chen J, Ma S, et al. Recent developments in multimodality fluorescence imaging probes. Acta Pharm Sin B. 2018;8(3):320–338. doi:10.1016/j.apsb.2018.03.01029881672
   PubMed Web of Science ®Google Scholar
• Haque A, Faizi M, Rather JA, Khan MS. Next generation NIR fluorophores for tumor imaging and fluorescence-guided surgery: a review. Bioorg Med Chem. 2017;25(7):2017–2034. doi:10.1016/j.bmc.2017.02.06128284863
   PubMed Web of Science ®Google Scholar
• Yi X, Wang F, Qin W, Yang X, Yuan J. Near-infrared fluorescent probes in cancer imaging and therapy: an emerging field. Int J Nanomedicine. 2014;9:1347–1365. doi:10.2147/IJN.S6020624648733
   PubMedGoogle Scholar
• Vallabani N, Singh S. Recent advances and future prospects of iron oxide nanoparticles in biomedicine and diagnostics. 3 Biotech. 2018;8(6):279. doi:10.1007/s13205-018-1286-z
   PubMedGoogle Scholar
• Blanco-Andujar C, Walter A, Cotin G, et al. Design of iron oxide-based nanoparticles for MRI and magnetic hyperthermia. Nanomedicine (Lond). 2016;11(14):1889–1910. doi:10.2217/nnm-2016-500127389703
   PubMed Web of Science ®Google Scholar
• Deng L, Cai X, Sheng D, et al. A laser-activated biocompatible theranostic nanoagent for targeted multimodal imaging and photothermal therapy. Theranostics. 2017;7(18):4410–4423. doi:10.7150/thno.2128329158836
   PubMed Web of Science ®Google Scholar
• Chen Q, Shang W, Zeng C, et al. Theranostic imaging of liver cancer using targeted optical/MRI dual-modal probes. Oncotarget. 2017;8(20):32741–32751. doi:10.18632/oncotarget.1564228416757
   PubMedGoogle Scholar
• Kim D, Rozhkova EA, Rajh T, Bader SD, Novosad V. Synthesis of hybrid gold/iron oxide nanoparticles in block copolymer micelles for imaging, drug delivery, and magnetic hyperthermia. Ieee T Magn. 2009;45(10):4821–4824. doi:10.1109/TMAG.2009.2024000
   Web of Science ®Google Scholar
• Vitol EA, Rozhkova EA, Rose V, et al. Efficient cisplatin pro-drug delivery visualized with sub-100 nm resolution: interfacing engineered thermosensitive magnetomicelles with a living system. Adv Mater Interfaces. 2014;1(7):1400182. doi:10.1002/admi.201400182
   Web of Science ®Google Scholar
• Veiseh O, Gunn JW, Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev. 2010;62(3):284–304. doi:10.1016/j.addr.2009.11.00219909778
   PubMed Web of Science ®Google Scholar
• Ai H, Flask C, Weinberg B, et al. Magnetite-loaded polymeric micelles as ultrasensitive magnetic-resonance probes. Adv Mater. 2005;17(16):1949–1952. doi:10.1002/adma.200401904
   Web of Science ®Google Scholar
• Upponi JR, Jerajani K, Nagesha DK, et al. Polymeric micelles: theranostic co-delivery system for poorly water-soluble drugs and contrast agents. Biomaterials. 2018;170:26–36. doi:10.1016/j.biomaterials.2018.03.05429649747
   PubMed Web of Science ®Google Scholar
• Wang R, Xiao R, Zeng Z, Xu L, Wang J. Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery. Int J Nanomedicine. 2012;7:4185–4198. doi:10.2147/IJN.S3448922904628
   PubMed Web of Science ®Google Scholar
• Xie W, Guo Z, Gao F, et al. Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics. Theranostics. 2018;8(12):3284–3307. doi:10.7150/thno.2522029930730
   PubMed Web of Science ®Google Scholar
• Che J, Okeke CI, Hu ZB, Xu J. DSPE-PEG: a distinctive component in drug delivery system. Curr Pharm Des. 2015;21(12):1598–1605.25594410
   PubMed Web of Science ®Google Scholar
• Muthiah M, Park I, Cho C. Surface modification of iron oxide nanoparticles by biocompatible polymers for tissue imaging and targeting. Biotechnol Adv. 2013;31(8):1224–1236. doi:10.1016/j.biotechadv.2013.03.00523528431
   PubMedGoogle Scholar
• Ferreira CDA, Fuscaldi LL, Townsend DM, Rubello D, Barros ALBD. Radiolabeled bombesin derivatives for preclinical oncological imaging. Biomed Pharmacother. 2017;87:58–72. doi:10.1016/j.biopha.2016.12.08328040598
   PubMedGoogle Scholar
• Moreno P, Ramos-Álvarez I, Moody TW, Jensen RT. Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment. Expert Opin Ther Tar. 2016;20(9):1055–1073. doi:10.1517/14728222.2016.1164694
   PubMed Web of Science ®Google Scholar
• Sancho V, Di Florio A, Moody TW, Jensen RT. Bombesin receptor-mediated imaging and cytotoxicity: review and current status. Curr Drug Deliv. 2011;8(1):79–134.21034419
   PubMed Web of Science ®Google Scholar
• Ramos-Álvarez I, Moreno P, Mantey SA, et al. Insights into bombesin receptors and ligands: highlighting recent advances. Peptides. 2015;72:128–144. doi:10.1016/j.peptides.2015.04.02625976083
   PubMed Web of Science ®Google Scholar
• Jafari A, Salouti M, Shayesteh SF, et al. Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI. Nanotechnology. 2015;26(7):75101. doi:10.1088/0957-4484/26/7/075101
   PubMed Web of Science ®Google Scholar
• Martin AL, Hickey JL, Ablack AL, Lewis JD, Luyt LG, Gillies ER. Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells. J Nanopart Res. 2009;12(5):1599–1608. doi:10.1007/s11051-009-9681-322328862
   PubMedGoogle Scholar
• Lee CM, Jeong HJ, Cheong SJ, et al. Prostate cancer-targeted imaging using magnetofluorescent polymeric nanoparticles functionalized with bombesin. Pharm Res. 2010;27(4):712–721. doi:10.1007/s11095-010-0072-320182773
   PubMedGoogle Scholar
• Montet X, Weissleder R, Josephson L. Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas. Bioconjug Chem. 2006;17(4):905–911. doi:10.1021/bc060035+16848396
   PubMedGoogle Scholar
• Sun S, Zeng H, Robinson DB, et al. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc. 2004;126(1):273–279. doi:10.1021/ja038085214709092
   PubMed Web of Science ®Google Scholar
• Inoue Y, Izawa K, Yoshikawa K, Yamada H, Tojo A, Ohtomo K. In vivo fluorescence imaging of the reticuloendothelial system using quantum dots in combination with bioluminescent tumour monitoring. Eur J Nucl Med Mol Imaging. 2007;34(12):2048–2056. doi:10.1007/s00259-007-0583-217885753
   PubMedGoogle Scholar
• Louie A. Multimodality imaging probes: design and challenges. Chem Rev. 2010;110(5):3146–3195. doi:10.1021/cr900353820225900
   PubMed Web of Science ®Google Scholar
• Ehlerding EB, Grodzinski P, Cai W, Liu CH. Big potential from small agents: nanoparticles for imaging-based companion diagnostics. ACS Nano. 2018;12(3):2106–2121. doi:10.1021/acsnano.7b0725229462554
   PubMedGoogle Scholar
• Xing Y, Zhao J, Conti PS, Chen K. Radiolabeled nanoparticles for multimodality tumor imaging. Theranostics. 2014;4(3):290–306. doi:10.7150/thno.734124505237
   PubMed Web of Science ®Google Scholar
• Hsu JC, Naha PC, Lau KC, et al. An all-in-one nanoparticle (AION) contrast agent for breast cancer screening with DEM-CT-MRI-NIRF imaging. Nanoscale. 2018;10(36):17236–17248. doi:10.1039/c8nr03741h30191237
   PubMed Web of Science ®Google Scholar
• Xie J, Chen K, Huang J, et al. PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials. 2010;31(11):3016–3022. doi:10.1016/j.biomaterials.2010.01.01020092887
   PubMed Web of Science ®Google Scholar
• Kim E, Kim JM, Kim L, et al. The effect of neutral-surface iron oxide nanoparticles on cellular uptake and signaling pathways. Int J Nanomedicine. 2016;11:4595–4607. doi:10.2147/IJN.S11033227695320
   PubMed Web of Science ®Google Scholar
• Sadat SMA, Jahan ST, Haddadi A. Effects of size and surface charge of polymeric nanoparticles on in vitro and in vivo applications. J Biomater Nanobiotechnol. 2016;07(02):91–108. doi:10.4236/jbnb.2016.72011
   Google Scholar
• Qiu Y, Liu Y, Wang L, et al. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials. 2010;31(30):7606–7619. doi:10.1016/j.biomaterials.2010.06.05120656344
   PubMed Web of Science ®Google Scholar
• Bartneck M, Keul HA, Singh S, et al. Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry. ACS Nano. 2010;4(6):3073–3086. doi:10.1021/nn100262h20507158
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu L, Chen H, et al. Surface impact on nanoparticle-based magnetic resonance imaging contrast agents. Theranostics. 2018;8(9):2521–2548. doi:10.7150/thno.2378929721097
   PubMed Web of Science ®Google Scholar
• Zhu L, Wang D, Wei X, et al. Multifunctional pH-sensitive superparamagnetic iron-oxide nanocomposites for targeted drug delivery and MR imaging. J Control Release. 2013;169(3):228–238. doi:10.1016/j.jconrel.2013.02.01523485450
   PubMedGoogle Scholar
• Nasongkla N, Bey E, Ren J, et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 2006;6(11):2427–2430. doi:10.1021/nl061412u17090068
   PubMed Web of Science ®Google Scholar
• Tong S, Hou S, Zheng Z, Zhou J, Bao G. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity. Nano Lett. 2010;10(11):4607–4613. doi:10.1021/nl102623x20939602
   PubMed Web of Science ®Google Scholar
• Kim DH, Vitol EA, Liu J, et al. Stimuli-responsive magnetic nanomicelles as multifunctional heat and cargo delivery vehicles. Langmuir. 2013;29(24):7425–7432. doi:10.1021/la304415823351096
   PubMed Web of Science ®Google Scholar
• Stoykow C, Erbes T, Maecke HR, et al. Gastrin-releasing peptide receptor imaging in breast cancer using the receptor antagonist 68Ga-RM2 and PET. Theranostics. 2016;6(10):1641–1650. doi:10.7150/thno.1495827446498
   PubMed Web of Science ®Google Scholar
• Zang J, Mao F, Wang H, et al. 68Ga-NOTA-RM26 PET/CT in the evaluation of breast cancer: a pilot prospective study. Clin Nucl Med. 2018;43(9):663–669. doi:10.1097/RLU.000000000000220930036253
   PubMed Web of Science ®Google Scholar
• Cai H, Xie F, Mulgaonkar A, et al. Bombesin functionalized 64Cu-copper sulfide nanoparticles for targeted imaging of orthotopic prostate cancer. Nanomedicine (Lond). 2018;13. doi:10.2217/nnm-2018-0062
   Web of Science ®Google Scholar
• Zhou Z, Wagh NK, Ogbomo SM, et al. Synthesis and in vitro and in vivo evaluation of hypoxia-enhanced 111In-bombesin conjugates for prostate cancer imaging. J Nucl Med. 2013;54(9):1605–1612. doi:10.2967/jnumed.112.11798623896558
   PubMedGoogle Scholar